Last reviewed · How we verify
Placebo (for Pentoxifylline)
A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect.
A placebo contains no active pharmaceutical ingredient and produces no pharmacological effect. Used for Control arm in clinical trials for Pentoxifylline efficacy evaluation.
At a glance
| Generic name | Placebo (for Pentoxifylline) |
|---|---|
| Also known as | Placebo(non treatment) |
| Sponsor | National Taiwan University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to establish the efficacy of active drugs through comparison. Any observed effects in placebo groups are attributed to the placebo effect—psychological and physiological responses to the expectation of treatment rather than to a drug mechanism. In this case, the placebo is being used as a control arm in trials evaluating Pentoxifylline.
Approved indications
- Control arm in clinical trials for Pentoxifylline efficacy evaluation
Common side effects
Key clinical trials
- Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation (PHASE2)
- Pentoxifylline in Patients With Ulcerative Colitis (PHASE2)
- Pentoxifylline in Diabetic Kidney Disease (PHASE4)
- Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible (PHASE3)
- Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial (NA)
- Pentoxifylline PKB171 Gel in Healthy Females Volunteers (PHASE1)
- PKB171 Against Placebo in Couples With Asthenozoospermia Who Wish to Conceive (PHASE2)
- Trental for the Treatment of Vertigo/Dizziness/Imbalance (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for Pentoxifylline) CI brief — competitive landscape report
- Placebo (for Pentoxifylline) updates RSS · CI watch RSS
- National Taiwan University Hospital portfolio CI